Lupus Science & Medicine™
Lupus Science & Medicine™ is a peer-reviewed, open access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking lupus studies. Lupus Science & Medicine™ (LS&M) is owned by the Lupus Foundation of America and published by BMJ, a respected global provider of evidence-based medical knowledge.
In 2021, LS&M received its first Impact Factor (IF) of 4.235. This is the highest current ranking IF for any lupus-specific journal and is closely ranked among the most prominent journals in rheumatology.
Below, LS&M Co-Editor-in-Chief, Dr. Jill Buyon, discusses what makes this journal so special for lupus researchers and clinicians.
Research on lupus will be considered from fields including, but not limited to, rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry. Submissions from groups of investigators engaged in international collaborations are especially encouraged. *Use code LFA04 for 25% off your submission – valid until March 31, 2020*
Submit Now
New articles are added year-round so the online content always includes the latest developments in lupus research and treatment.
Articles cover the latest developments from basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
Want to know about the hottest topics in lupus research? Check out the list of 'most read articles' on Lupus Science & Medicine™.
Be the first to know. Sign up to receive an eTOC Alerts when a new article is published on Lupus Science & Medicine.
Authors discuss their research findings and provide additional insight into their conclusions.
2019 vs. 2018 Growth Statistics
Growth in Online Usage
Increase in Users Accessing Content
Number of Online Mentions for Content
Lupus Science & Medicine™ is edited by Jill P. Buyon, Division Director of Rheumatology, Professor of Medicine at New York University School of Medicine; and Ronald F. van Vollenhoven, Professor and Chief, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden. The journal has also assembled a world-class team of associate editors and an editorial board to maintain the journal's high standards, high visibility, and credibility.
The Lupus Science & Medicine team is delighted to welcome Dr Joan Merrill to the board as an Associate Editor from January 2022. Dr Merrill is the Chief Advisor for Clinical Development for the Lupus Foundation of America (LFA) and is a major leader in lupus trial design, innovating new ways to tackle the heterogeneity inherent in this complex disease. In addition to her own studies, Dr Merrill also works with the LFA to train investigators for trials worldwide.
We look forward to working with Dr Merrill, and thank her in advance for the valued contributions she will bring to the journal.